Cargando…

Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma

Molecular prognostic signatures are critical for treatment decision-making in esophageal squamous cell cancer (ESCC), but the robustness of these signatures is limited. The aberrant DNA damage response (DDR) pathway may lead to the accumulation of mutations and thus accelerate tumor progression in E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Weitao, Ben, Xiaosong, Zhou, Zihao, Ding, Yu, Tang, Yong, Huang, Shujie, Deng, Cheng, Liao, Yuchen, Zhou, Qiaoxia, Zhao, Jing, Wang, Guoqiang, Xu, Yu, Wen, Xiaofang, Zhang, Yuzi, Cai, Shangli, Chen, Rixin, Qiao, Guibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716225/ https://www.ncbi.nlm.nih.gov/pubmed/34976055 http://dx.doi.org/10.1155/2021/3726058

Ejemplares similares

The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma
por: Zhuang, Weitao, et al.
Publicado: (2022)

Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study
por: Qiao, Guibin, et al.
Publicado: (2021)

Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma
por: Wu, Hansheng, et al.
Publicado: (2021)

A novel prognostic model: which group of esophageal squamous cell carcinoma patients could benefit from adjuvant chemotherapy
por: Zhou, Zihao, et al.
Publicado: (2022)

A validated nomogram integrating hematological indicators to predict response to neoadjuvant therapy in esophageal squamous cell carcinoma patients
por: Wang, Sichao, et al.
Publicado: (2021)

Accuracy of next-generation sequencing for molecular profiling of small specimen of lung cancer: a prospective pilot study of side-by-side comparison
por: Ben, Xiaosong, et al.
Publicado: (2022)

Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma—A Real-World Multicenter Study (RICE-Retro)
por: Huang, Shujie, et al.
Publicado: (2022)

Risk factors associated with prolonged viral clearance in patients with a refractory course of COVID-19: a retrospective study
por: Zhuang, Weitao, et al.
Publicado: (2021)

Development and validation of an inflammatory response-related gene and clinical factor-based signature for predicting prognosis in gastric cancer
por: Li, Suihui, et al.
Publicado: (2023)

Salivary microbiota may predict the presence of esophageal squamous cell carcinoma
por: Wei, Junmin, et al.
Publicado: (2021)

Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients
por: Zhuang, Weitao, et al.
Publicado: (2021)

Surgical resection of primary tumors improved the prognosis of patients with bone metastasis of non-small cell lung cancer: a population-based and propensity score-matched study
por: Tian, Dan, et al.
Publicado: (2021)

Factors influencing negative surgical outcomes in adult pectus excavatum patients undergoing Nuss procedure
por: Gao, Zhen, et al.
Publicado: (2021)

Should psychological distress be listed as a surgical indication for indeterminate pulmonary nodules: protocol for a prospective cohort study in real-world settings
por: Zhuang, Weitao, et al.
Publicado: (2022)

A prognostic signature based on adenosine metabolism related genes for ovarian cancer
por: Liang, Weifeng, et al.
Publicado: (2022)

Pregnancy-associated lung cancer: a clinical and scientific challenge more than treatment dilemma
por: Zhuang, Weitao, et al.
Publicado: (2021)

Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma
por: Li, Minjuan, et al.
Publicado: (2020)

Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma
por: Mao, Guangxian, et al.
Publicado: (2023)

Correlation between Clinicopathology and Expression of Heat Shock Protein 72 and Glycoprotein 96 in Human Esophageal Squamous Cell Carcinoma
por: Wang, Xiaoping, et al.
Publicado: (2010)

A case report of immune checkpoint inhibitor nivolumab combined with anti-angiogenesis agent anlotinib for advanced esophageal squamous cell carcinoma
por: Tang, Yong, et al.
Publicado: (2019)

Persistent Somatic Symptom Burden and Sleep Disturbance in Patients with COVID-19 During Hospitalization and After Discharge: A Prospective Cohort Study
por: Huang, Shujie, et al.
Publicado: (2021)

Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer
por: Wang, Zhiyu, et al.
Publicado: (2022)

Exploring the psychological profile: a cross-sectional study of 1,185 patients with pulmonary nodules in an outpatient clinic
por: Zhuang, Weitao, et al.
Publicado: (2022)

Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma
por: Shi, Xiaobo, et al.
Publicado: (2022)

Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?: authors reply
por: Gao, Zhen, et al.
Publicado: (2023)

Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis
por: Gao, Zhen, et al.
Publicado: (2023)

Germline and somatic variations influence the somatic mutational signatures of esophageal squamous cell carcinomas in a Chinese population
por: Guo, Jintao, et al.
Publicado: (2018)

Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes
por: Qiu, Zhiquan, et al.
Publicado: (2022)

Plasma cfDNA methylation markers for the detection and prognosis of ovarian cancer
por: Liang, Leilei, et al.
Publicado: (2022)

Senescence-related genes define prognosis, immune contexture, and pharmacological response in gastric cancer
por: Shen, Xiaogang, et al.
Publicado: (2023)

Predictive value of the presence of Prevotella and the ratio of Porphyromonas gingivalis to Prevotella in saliva for esophageal squamous cell carcinoma
por: Chen, Xiaohui, et al.
Publicado: (2022)

Minimally invasive surgery vs. open thoracotomy for non-small-cell lung cancer with N2 disease: a systematic review and meta-analysis
por: Liu, Songlin, et al.
Publicado: (2023)

Developing a Diagnostic Model to Predict the Risk of Asthma Based on Ten Macrophage-Related Gene Signatures
por: Ai, Xiaoshun, et al.
Publicado: (2022)

A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer
por: Ren, Qianhe, et al.
Publicado: (2023)

A novel serum microRNA signature to screen esophageal squamous cell carcinoma
por: Huang, Zebo, et al.
Publicado: (2016)

Autophagy-Related Three-Gene Prognostic Signature for Predicting Survival in Esophageal Squamous Cell Carcinoma
por: Cui, Heyang, et al.
Publicado: (2021)

Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma
por: Lin, Zheng, et al.
Publicado: (2022)

Identification of a three-gene prognostic signature for radioresistant esophageal squamous cell carcinoma
por: Wang, Xiao-Yan, et al.
Publicado: (2023)

Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma
por: Zheng, Bohao, et al.
Publicado: (2023)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jbdm3eh786lmnluaelmcanme7q